Loading…
Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction
Aims We evaluated the extent to which left ventricular diastolic dysfunction (LVDD) contributes to the high false‐positive rates observed when natriuretic peptides (NPs) are used to screen for left ventricular systolic dysfunction (LVSD), and the use of NPs in combination with electrocardiogram (ECG...
Saved in:
Published in: | European journal of heart failure 2012-05, Vol.14 (5), p.480-486 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aims
We evaluated the extent to which left ventricular diastolic dysfunction (LVDD) contributes to the high false‐positive rates observed when natriuretic peptides (NPs) are used to screen for left ventricular systolic dysfunction (LVSD), and the use of NPs in combination with electrocardiogram (ECG) to screen for pre‐clinical ventricular dysfunction (PCVD).
Methods and results
Eight hundred and fourteen patients over 40 years of age and with at least one cardiovascular risk factor were recruited. Screening strategies for LVSD included brain natriuretic peptide (BNP) alone at cut‐offs of 20, 50, and 100 pg/mL, and BNP and abnormal ECG combined. Systolic and diastolic function was assessed by Doppler echocardiography. A left ventricular ejection fraction (LVEF) of |
---|---|
ISSN: | 1388-9842 1879-0844 |
DOI: | 10.1093/eurjhf/hfs030 |